Last reviewed · How we verify

NCT06964204

The Effect of Kangaroo Care and Lullaby on Mother-Baby Physiological Parameters and Mother's State Anxiety Level

Not yet recruiting NA Last updated 9 May 2025
What this trial tests

NA trial testing Kangaroo Care in The Gestational Age of the Newborn is Between 28-37 Weeks in 57 participants. Not yet recruiting.

Timeline
15 May 2025
Primary endpoint
15 September 2025
15 September 2025

Quick facts

Lead sponsorKirsehir Ahi Evran Universitesi
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment57
Start date15 May 2025
Primary completion15 September 2025
Estimated completion15 September 2025

Drugs / interventions tested

Conditions studied

Sponsor

Kirsehir Ahi Evran Universitesi — full company profile →

Who can join

Adults 28 Weeks to 37 Weeks, any sex, with The Gestational Age of the Newborn is Between 28-37 Weeks or Stable Health Status of the Newborn. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was planned to investigate the effect of kangaroo care and lullaby on mother-baby physiologic parameters and mother's state anxiety level in premature newborns.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Kangaroo Care

Trials testing the same drug.

Other Kirsehir Ahi Evran Universitesi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06964204.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing